UNLABELLED: Acute hemorrhagic edema of young children is a rare leukocytoclastic vasculitis that has been reported exclusively in small retrospective cases series, case reports, or quizzes. Considering that retrospective experience deserves confirmation in at least one observational prospective study, we present our experience with 16 children (12 boys and 4 girls, 5-28 months of age) affected by acute hemorrhagic edema. The patients were in good general conditions and with a low-grade or even absent fever. They presented with non-itching red to purpuric targetoid lesions not changing location within hours, with non-pitting and sometimes tender indurative swelling, and without mucous membrane involvement or scratch marks. Signs for articular, abdominal, or kidney involvement were absent. Antinuclear or antineutrophil cytoplasmic autoantibodies were never detected. The cases were managed symptomatically as outpatients and fully resolved within 4 weeks or less. No recurrence or familiarity was noted. CONCLUSION: This is the first prospective evaluation of hemorrhagic edema. Our findings emphasize its distinctive tetrad: a well-appearing child; targetoid lesions that do not change location within hours; non-pitting, sometimes tender edema; complete resolution without recurrence. What is known • Acute hemorrhagic edema of young children is considered a benign vasculitis. • There have been ≈100 cases reported in small retrospective case series. What is new • The first prospective evaluation of this condition emphasizes its features: febrile prodrome; well-appearing child; targetoid lesions not changing location within hours; non-pitting, sometimes tender indurative edema; absent extracutaneous involvement; resolution within 3 weeks. • Antineutrophil cytoplasmic autoantibodies do not play a pathogenic role.
UNLABELLED: Acute hemorrhagic edema of young children is a rare leukocytoclastic vasculitis that has been reported exclusively in small retrospective cases series, case reports, or quizzes. Considering that retrospective experience deserves confirmation in at least one observational prospective study, we present our experience with 16 children (12 boys and 4 girls, 5-28 months of age) affected by acute hemorrhagic edema. The patients were in good general conditions and with a low-grade or even absent fever. They presented with non-itching red to purpuric targetoid lesions not changing location within hours, with non-pitting and sometimes tender indurative swelling, and without mucous membrane involvement or scratch marks. Signs for articular, abdominal, or kidney involvement were absent. Antinuclear or antineutrophil cytoplasmic autoantibodies were never detected. The cases were managed symptomatically as outpatients and fully resolved within 4 weeks or less. No recurrence or familiarity was noted. CONCLUSION: This is the first prospective evaluation of hemorrhagic edema. Our findings emphasize its distinctive tetrad: a well-appearing child; targetoid lesions that do not change location within hours; non-pitting, sometimes tender edema; complete resolution without recurrence. What is known • Acute hemorrhagic edema of young children is considered a benign vasculitis. • There have been ≈100 cases reported in small retrospective case series. What is new • The first prospective evaluation of this condition emphasizes its features: febrile prodrome; well-appearing child; targetoid lesions not changing location within hours; non-pitting, sometimes tender indurative edema; absent extracutaneous involvement; resolution within 3 weeks. • Antineutrophil cytoplasmic autoantibodies do not play a pathogenic role.
Entities:
Keywords:
Acute hemorrhagic edema of young children; Antineutrophil cytoplasmic autoantibodies; Child; Finkelstein–Seidlmayer disease; Leukocytoclastic vasculitis
Authors: Alessandro Ostini; Gian Paolo Ramelli; Carlo Mainetti; Mario G Bianchetti; Alessandra Ferrarini Journal: Acta Derm Venereol Date: 2015-05 Impact factor: 4.437
Authors: Hakan M Poyrazoğlu; Hüseyin Per; Zübeyde Gündüz; Ruhan Düşünsel; Duran Arslan; Nazmi NarIn; Hakan Gümüş Journal: Pediatr Int Date: 2003-12 Impact factor: 1.524
Authors: D Lambert; R Laurent; D Bouilly; C Saint-Mont; J M Estavoyer; P Agache; J L Chapuis Journal: Ann Dermatol Venereol Date: 1979-12 Impact factor: 0.777
Authors: I Krause; A Lazarov; A Rachmel; M M Grunwald; A Metzker; B Z Garty; S Halevy; M Nitzan Journal: Acta Paediatr Date: 1996-01 Impact factor: 2.299
Authors: Gregorio Paolo Milani; Rosa Maria Dellepiane; Massimo Luca Castellazzi; Marta Benedetta Maria Mazzoni; Mario Giovanni Bianchetti; Emilio Filippo Fossali Journal: Pediatr Int Date: 2013-08 Impact factor: 1.524
Authors: Ricardo M Suehiro; Bianca S Soares; Adriana P Eisencraft; Lucia M M A Campos; Clovis A A Silva Journal: Turk J Pediatr Date: 2007 Apr-Jun Impact factor: 0.552
Authors: Vera Ramelli; Sebastiano A G Lava; Giacomo D Simonetti; Mario G Bianchetti; Gian Paolo Ramelli; Gregorio P Milani Journal: Eur J Pediatr Date: 2017-02-04 Impact factor: 3.183
Authors: Sebastiano A G Lava; Gregorio P Milani; Emilio F Fossali; Giacomo D Simonetti; Carlo Agostoni; Mario G Bianchetti Journal: Clin Rev Allergy Immunol Date: 2017-12 Impact factor: 10.817
Authors: Giulia Rosti; Gregorio P Milani; Emanuela A Laicini; Emilio F Fossali; Mario G Bianchetti Journal: Ital J Pediatr Date: 2017-09-21 Impact factor: 2.638